Current Liabilities
Lease Liability Payments - 2020 (Remaining Three Months)
Neurocrine Biosciences Lease Liability Payments - 2020 (Remaining Three Months) increased by 353.6% to $44.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 35.4%, from $32.50M to $44.00M.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
First reportedQ2 2020
Last reportedQ1 2026May 5, 2026
Metric ID:
lease_liability_payments_2020_remaining_3mHistorical Data
15 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $7.10M | $3.50M | $13.00M | $8.70M | $4.40M | $13.50M | $9.10M | $4.50M | $26.90M | $18.00M | $9.00M | $32.50M | $23.10M | $9.70M | $44.00M |
| QoQ Change | — | -50.7% | +271.4% | -33.1% | -49.4% | +206.8% | -32.6% | -50.5% | +497.8% | -33.1% | -50.0% | +261.1% | -28.9% | -58.0% | +353.6% |
| YoY Change | — | — | — | +22.5% | +25.7% | +3.8% | +4.6% | +2.3% | +99.3% | +97.8% | +100.0% | +20.8% | +28.3% | +7.8% | +35.4% |
Range$3.50M – $44.00M
CAGR+68.4%
Avg YoY Growth+37.4%
Median YoY Growth+24.1%
Lease Liability Payments - 2020 (Remaining Three Months) at Other Companies
Frequently Asked Questions
- What is Neurocrine Biosciences's lease liability payments - 2020 (remaining three months)?
- Neurocrine Biosciences (NBIX) reported lease liability payments - 2020 (remaining three months) of $44.00M in Q1 2026.
- How has Neurocrine Biosciences's lease liability payments - 2020 (remaining three months) changed year-over-year?
- Neurocrine Biosciences's lease liability payments - 2020 (remaining three months) increased by 35.4% year-over-year, from $32.50M to $44.00M.